Alzamend Neuro, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.72 | -100% | -1.69 | -100% |
| P/S |
|
0 | 33.75 | -100% |
|
|
| P/BV |
|
-1.85 | 4.82 | -138.49% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-0.4789 | -22.17 | -97.84% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-0.5625 | 68.75 | -100.82% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.98 | -100% | 0 | 0% |
| ROE |
|
-4408.31 | 9.61 | -45964.55% |
|
|
| ROA |
|
-303.88 | 0.3443 | -88369.84% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
383.07 | 15.35 | 2395.54% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0304 | -3.68 | -99.17% | -0.0257 | +18.27% |
| Nеt Debt/Ebitda |
|
0.0076 | -3.44 | -100.22% |
|
|
| Debt/Ratio |
|
0.4761 | 0.1985 | 139.88% |
|
|
| Debt/Equity |
|
3.77 | 1.66 | 126.58% |
|
|
| Debt/Net Income |
|
-0.0302 | 10.32 | -100.29% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5473 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.498 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5473 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -56.89 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
124.7 | -54.68 | -328.05% | ||
| Growth impulse Net Income in 5 years |
|
126.09 | -58.33 | -316.17% | ||
| Growth impulse FCF in 5 years |
|
265.97 | -49.48 | -637.53% | ||
| Growth impulse EPS in 5 years |
|
29906.76 | -32.41 | -92376.33% |
IP Score
4.15/10
